While Rybelsus introduces unique benefits, users should weigh these against the chances of some side effects occurring, and the costs that come along for the ride
(PubMed) Zeisel SH
The clinical data showed the 4 mg group achieving 17.1% body weight reduction at 48 weeks, which already exceeds what most single-receptor GLP-1 agonists deliver at their maximum doses
Genetica e risposta ai farmaci GLP-1: nuovo studio su Nature Un recente studio pubblicato su Nature ha dimostrato che la risposta ai farmaci per l'obesit (come Semaglutide e Tirzepatide) influenzata da fattori genetici
While their main role remains in diabetes treatment, certain GLP-1 therapies are also approved for weight management in individuals with obesity or overweight with comorbidities, given their modest but clinically meaningful effects on appetite regulation and body weight 2 , 6 , 7
Building long-term eating habits beyond GLP-1 GLP-1 therapy is not permanent for most people